Publication:
Community-acquired hypokalemia in elderly patients: related factors and clinical outcomes

dc.contributor.authorBardak, Simge
dc.contributor.authorTurgutalp, Kenan
dc.contributor.authorKoyuncu, Mahmut Bakır
dc.contributor.authorHarı, H.
dc.contributor.authorHelvacı, İlter
dc.contributor.authorOvla, Didem
dc.contributor.authorHoroz, Mehmet
dc.contributor.authorDemir, Serap Baspinar
dc.contributor.authorKıykım, Ahmet Alper
dc.contributor.institutionBardak, Simge, Department of Internal Medicine, Mersin Üniversitesi Tip Fakültesi, Mersin, Turkey
dc.contributor.institutionTurgutalp, Kenan, Department of Internal Medicine, Mersin Üniversitesi Tip Fakültesi, Mersin, Turkey
dc.contributor.institutionKoyuncu, Mahmut Bakır, Department of Internal Medicine, Mersin Üniversitesi Tip Fakültesi, Mersin, Turkey
dc.contributor.institutionHarı, H., Department of Internal Medicine, Mersin Üniversitesi Tip Fakültesi, Mersin, Turkey
dc.contributor.institutionHelvacı, İlter, Department of Business Information Management, Mersin Üniversitesi, Mersin, Turkey
dc.contributor.institutionOvla, Didem, Department of Biostatistics, Mersin Üniversitesi Tip Fakültesi, Mersin, Turkey
dc.contributor.institutionHoroz, Mehmet, Department of Internal Medicine, Bahçeşehir Üniversitesi, Istanbul, Turkey
dc.contributor.institutionDemir, Serap Baspinar, Department of Internal Medicine, Mersin Üniversitesi Tip Fakültesi, Mersin, Turkey
dc.contributor.institutionKıykım, Ahmet Alper, Department of Internal Medicine, Mersin Üniversitesi Tip Fakültesi, Mersin, Turkey
dc.date.accessioned2025-10-05T16:19:11Z
dc.date.issued2017
dc.description.abstractPurpose: Electrolyte imbalance is a common problem affecting the elderly. Increased number of comorbidities and frequent use of drugs may contribute to increased risk of hypokalemia in the elderly. This study was performed to investigate the prevalence of community-acquired hypokalemia (CAH), risk factors for its development, related factors with hypokalemia, and morbidities and all-cause mortality rates (MR) of CAH in the elderly patients. Methods: Total of 36,361 patients aged above 65 years were screened retrospectively. Group 1 consisted of 269 elderly patients with potassium level ≤3.5 mmol/L, and group 2 (control group) consisted of 182 subjects with potassium level between 3.6 and 5.5 mmol/L. Etiologic factors of CAH, presence of comorbidities, duration of hospital stay, hospital cost, and clinical outcomes were recorded. Results: Prevalence of hypokalemia was found 3.24% in patients aged above 65 years. Duration of hospital stay, presence of ≥2 comorbid diseases, hospital cost, and MR were significantly higher in group 1 compared to group 2 (p < 0.001 for all). Loop diuretics, hydrochlorothiazides, beta agonists, inadequate oral intake, and female gender were all independent risk factors for CAH in elderly patients. Patients with ≥2 comorbid diseases were found to have greater risk of hypokalemia than the patients with <2 comorbidities. Conclusions: Length of hospital stay, hospital cost, and MR were higher in elderly with CAH. Female gender, hydrochlorothiazides, loop diuretics, and ≥2 comorbid diseases are the leading risk factors associated with CAH in elderly. © 2017 Elsevier B.V., All rights reserved.
dc.identifier.doi10.1007/s11255-016-1489-3
dc.identifier.endpage489
dc.identifier.issn03011623
dc.identifier.issn15732584
dc.identifier.issue3
dc.identifier.pubmed28035617
dc.identifier.scopus2-s2.0-85007460178
dc.identifier.startpage483
dc.identifier.urihttps://doi.org/10.1007/s11255-016-1489-3
dc.identifier.urihttps://hdl.handle.net/20.500.14719/12138
dc.identifier.volume49
dc.language.isoen
dc.publisherSpringer Netherlands
dc.relation.sourceInternational Urology and Nephrology
dc.subject.authorkeywordsElderly
dc.subject.authorkeywordsGender
dc.subject.authorkeywordsHospital Cost
dc.subject.authorkeywordsHypokalemia
dc.subject.authorkeywordsPrevalence
dc.subject.authorkeywordsHydrochlorothiazide
dc.subject.authorkeywordsPotassium
dc.subject.authorkeywordsHydrochlorothiazide
dc.subject.authorkeywordsPotassium
dc.subject.authorkeywordsSodium Potassium Chloride Symporter Inhibitors
dc.subject.authorkeywordsBeta Adrenergic Receptor Stimulating Agent
dc.subject.authorkeywordsHydrochlorothiazide
dc.subject.authorkeywordsLoop Diuretic Agent
dc.subject.authorkeywordsPotassium
dc.subject.authorkeywordsAged
dc.subject.authorkeywordsArticle
dc.subject.authorkeywordsClinical Outcome
dc.subject.authorkeywordsCommunity Acquired Hypokalemia
dc.subject.authorkeywordsComorbidity
dc.subject.authorkeywordsControlled Study
dc.subject.authorkeywordsDisease Association
dc.subject.authorkeywordsFemale
dc.subject.authorkeywordsHospital Cost
dc.subject.authorkeywordsHuman
dc.subject.authorkeywordsHypokalemia
dc.subject.authorkeywordsLength Of Stay
dc.subject.authorkeywordsMajor Clinical Study
dc.subject.authorkeywordsMale
dc.subject.authorkeywordsMorbidity
dc.subject.authorkeywordsMortality Rate
dc.subject.authorkeywordsPatient Risk
dc.subject.authorkeywordsPotassium Blood Level
dc.subject.authorkeywordsPotassium Intake
dc.subject.authorkeywordsPotassium Replacement Therapy
dc.subject.authorkeywordsPrevalence
dc.subject.authorkeywordsRetrospective Study
dc.subject.authorkeywordsRisk Factor
dc.subject.authorkeywordsSex Difference
dc.subject.authorkeywordsSubstitution Therapy
dc.subject.authorkeywordsBlood
dc.subject.authorkeywordsCause Of Death
dc.subject.authorkeywordsTurkey
dc.subject.authorkeywordsVery Elderly
dc.subject.authorkeywordsAged
dc.subject.authorkeywordsAged, 80 And Over
dc.subject.authorkeywordsCause Of Death
dc.subject.authorkeywordsComorbidity
dc.subject.authorkeywordsFemale
dc.subject.authorkeywordsHospital Costs
dc.subject.authorkeywordsHumans
dc.subject.authorkeywordsHydrochlorothiazide
dc.subject.authorkeywordsHypokalemia
dc.subject.authorkeywordsLength Of Stay
dc.subject.authorkeywordsMale
dc.subject.authorkeywordsPotassium
dc.subject.authorkeywordsPrevalence
dc.subject.authorkeywordsRetrospective Studies
dc.subject.authorkeywordsRisk Factors
dc.subject.authorkeywordsSex Factors
dc.subject.authorkeywordsSodium Potassium Chloride Symporter Inhibitors
dc.subject.indexkeywordsbeta adrenergic receptor stimulating agent
dc.subject.indexkeywordshydrochlorothiazide
dc.subject.indexkeywordsloop diuretic agent
dc.subject.indexkeywordspotassium
dc.subject.indexkeywordsaged
dc.subject.indexkeywordsArticle
dc.subject.indexkeywordsclinical outcome
dc.subject.indexkeywordscommunity acquired hypokalemia
dc.subject.indexkeywordscomorbidity
dc.subject.indexkeywordscontrolled study
dc.subject.indexkeywordsdisease association
dc.subject.indexkeywordsfemale
dc.subject.indexkeywordshospital cost
dc.subject.indexkeywordshuman
dc.subject.indexkeywordshypokalemia
dc.subject.indexkeywordslength of stay
dc.subject.indexkeywordsmajor clinical study
dc.subject.indexkeywordsmale
dc.subject.indexkeywordsmorbidity
dc.subject.indexkeywordsmortality rate
dc.subject.indexkeywordspatient risk
dc.subject.indexkeywordspotassium blood level
dc.subject.indexkeywordspotassium intake
dc.subject.indexkeywordspotassium replacement therapy
dc.subject.indexkeywordsprevalence
dc.subject.indexkeywordsretrospective study
dc.subject.indexkeywordsrisk factor
dc.subject.indexkeywordssex difference
dc.subject.indexkeywordssubstitution therapy
dc.subject.indexkeywordsblood
dc.subject.indexkeywordscause of death
dc.subject.indexkeywordsTurkey
dc.subject.indexkeywordsvery elderly
dc.subject.indexkeywordsAged
dc.subject.indexkeywordsAged, 80 and over
dc.subject.indexkeywordsCause of Death
dc.subject.indexkeywordsComorbidity
dc.subject.indexkeywordsFemale
dc.subject.indexkeywordsHospital Costs
dc.subject.indexkeywordsHumans
dc.subject.indexkeywordsHydrochlorothiazide
dc.subject.indexkeywordsHypokalemia
dc.subject.indexkeywordsLength of Stay
dc.subject.indexkeywordsMale
dc.subject.indexkeywordsPotassium
dc.subject.indexkeywordsPrevalence
dc.subject.indexkeywordsRetrospective Studies
dc.subject.indexkeywordsRisk Factors
dc.subject.indexkeywordsSex Factors
dc.subject.indexkeywordsSodium Potassium Chloride Symporter Inhibitors
dc.titleCommunity-acquired hypokalemia in elderly patients: related factors and clinical outcomes
dc.typeArticle
dcterms.referencesAging Kidney in Health and Disease, (2008), Nephrology in 30 days, (2014), Brenner Rectors the Kidney, (2016), Kleinfeld, Morris J., Hypokalemia: are elderly females more vulnerable?, Journal of the National Medical Association, 85, 11, pp. 861-864, (1993), Kraft, Michael D., Treatment of electrolyte disorders in adult patients in the intensive care unit, American Journal of Health-System Pharmacy, 62, 16, pp. 1663-1682, (2005), Eliaçik, Eylem, Potassium abnormalities in current clinical practice: Frequency, causes, severity and management, Medical Principles and Practice, 24, 3, pp. 271-275, (2015), Kromhout, Daan, Potassium depletion and aging, Comprehensive Therapy, 3, 6, pp. 32-37, (1977), Gennari, F. John, Hypokalemia, New England Journal of Medicine, 339, 7, pp. 451-458, (1998), Sagild, Uffe, Total exchangeable potassium in normal subjects with special reference to changes with age, Scandinavian Journal of Clinical and Laboratory Investigation, 8, 1, pp. 44-50, (1956), Toner, J. M., Thiazide‐induced hypokalaemia, prevalence higher in women., British Journal of Clinical Pharmacology, 18, 3, pp. 449-452, (1984)
dspace.entity.typePublication
local.indexed.atScopus
person.identifier.scopus-author-id55314203400
person.identifier.scopus-author-id36085801700
person.identifier.scopus-author-id57140091700
person.identifier.scopus-author-id57192693620
person.identifier.scopus-author-id25029573000
person.identifier.scopus-author-id56500642500
person.identifier.scopus-author-id55924682900
person.identifier.scopus-author-id7006702488
person.identifier.scopus-author-id6603858014

Files